at 2101

H-201-70 is a partial beta1 agonist with adrenoreceptor stimulatory effects.

Afegostat is an acid β-glucosidase (GCase) active site inhibitor that acts as a pharmacological chaperone. Afegostat inhibits GCase with K(i) ~30 nM for wild-type and mutant enzymes. Afegostat was an experimental drug for the treatment of certain forms of

S 2101 is an inhibitor of lysine-specific demethylase 1 (LSD1)(IC50 of 0.99 μM, Ki of 0.61 μM and Kinact Ki of 4560 M s).

PKUMDL-WQ-2101 是磷酸甘油酸脱氢酶的选择性变构抑制剂，具有抗肿瘤活性。